SHCS

Swiss HIV Cohort Study

& Swiss Mother and Child HIV Cohort Study

Adland et al., HLA-B*27:02-mediated control of HIV-1

8th November, 2018

Differential immunodominance hierarchy of CD8+ T-cell responses in HLA-B*27:05- and -B*27:02-mediated control of HIV-1 infection.    Journal of Virology

The association between HLA-B*27:05 and protection against HIV disease progression in untreated HIV-seropositive individuals has been linked to immunodominant HLA-B*27:05- restricted CD8* T-cell responses toward the conserved Gag KK10.

In this study, Adland et al. aimed to study the impact of the 3 amino acid differences between HLA-B*27:05 and the closely related HLA-B*27:02 on the HIV-specific CD8+ T-cell response hierarchy and on immune control of HIV. They found that both HLA-B*27:02 and HLA-B*27:05 were associated with slower disease progression and lower viral loads. However, the effect of HLA-B*27:02 appeared to be consistently stronger than that of HLAB*27:05. In contrast to HLA-B*27:05, the immunodominant HIV-specific HLA-B*27:02-restricted CD8+ T-cell response is to a Nef epitope. Analysis of autologous virus sequences showed that in HLA-B*27:02-positive subjects, all CD8+ T-cell responses impose selection pressure on the virus, whereas in HLA-B*27:05-positive subjects, there is no Nef mediated selection pressure.

These findings indicate that the immunodominant HLA-B*27:02-restricted Nef response adds to protection mediated by the Gag and Pol specificities that dominate anti-HIV CD8+ T-cell activity in HLA-B*27:05-positive subjects.

PubMed

SHCS public beta

If you spot a bug or have a suggestion, let us know:

What happened? (Details help!)
What device are you using?
Screenshot? (Optional but helpful)

Your feedback goes straight to the SHCS dev team and helps us improve faster.
Thanks for making the SHCS website better!

You can upload up to 5 images (JPG or PNG only).